资讯

FDA says it will phase out animal testing requirement for monoclonal antibodies and drugs
The US Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies ...
Tampa Free Press on MSN4 小时
FDA Announces Groundbreaking Shift: Replacing Animal Testing With Advanced Human-Relevant ...
In a landmark decision poised to revolutionize drug development, the U.S. Food and Drug Administration (FDA) has announced a ...
To promote drug safety, FDA to replace animal testing with AI-based experiments, other methods
The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial ...
MyChesCo on MSN1 天
FDA to Replace Animal Testing with Human-Relevant Methods for Drug Development
The U.S. Food and Drug Administration (FDA) has announced an ambitious effort to modernize drug testing by reducing reliance ...
Charles River Labs Stock (CRL) Crashes 28% as FDA Signals End of Animal Testing Era
Shares of Charles River Labs (CRL) crashed 28% after the U.S. FDA (Food and Drug Administration) announced plans to phase out the need for ...
FDA phasing out some animal testing in 'win-win' for ethics and public health: commissioner
The FDA is phasing out an animal testing requirement for monoclonal antibody therapies in favor of testing drugs on “lab-grown human ‘organoids.'" ...
The American Journal of Managed Care5 小时
Standardized Testing, Moves to Oral Therapy, and Cost Challenges Get Attention
Moreover, the panelists emphasized that real-world evidence goes beyond clinical trial data. It involves continuous patient monitoring, proactive adverse effect management, and adapting protocols ...
Medscape3 天
Monoclonal Antibodies in Rheumatoid Arthritis
No writing assistance was utilized in the production of this manuscript. Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA).
Inotiv drops after FDA says phasing out animal testing of monoclonal antibodies
Shares of Inotiv (NOTV) were down $1.39, or 50%, to $1.42 near the close of trading after the Food and Drug Administration announced that it is ...
The New England Journal of Medicine5 天
A Phase 3 Trial of Inebilizumab in Generalized Myasthenia Gravis
Autoimmune generalized myasthenia gravis is a disease that manifests with fluctuating muscle weakness. Inebilizumab is a ...
University of Birmingham18 小时
Support for new test to monitor people at risk of multiple myeloma
The new time-saving test is intended for people with MGUS (Monoclonal Gammopathy of Unknown Significance), a precursor condition of myeloma.
Managed Healthcare Executive13 天
Monoclonal Antibody Bentracimab Shown to Reverse Antiplatelet Effect of Brilinta | ACC 2025
A BLA has been filed for bentracimab and, if approved, has the potential to be the first therapy to reverse the effects of ...